Peptide-based versus standard polymeric enteral nutrition in the PICU: a multicenter observational study

Merve Misirlioglu Celik1, Dincer Yildizdas2, Faruk Ekinci2

  • 1Department of Pediatric Intensive Care Unit, Mersin University Faculty of Medicine, Mersin, Türkiye.

Insights

Peptide-based formulas (PBF) in pediatric intensive care units (PICUs) were associated with lower infection rates and constipation compared to standard polymeric formulas (SPF). While SPF provided earlier caloric intake, outcomes were similar by day 7, suggesting individualized formula selection.

Area of Science:

  • Pediatric critical care medicine
  • Clinical nutrition
  • Gastroenterology

Background:

  • Standard polymeric formulas (SPF) are recommended for enteral nutrition in critically ill children.
  • Peptide-based formulas (PBF) are increasingly used to enhance enteral nutrition and mitigate complications.
  • This study compares clinical outcomes of PBF versus SPF in pediatric intensive care units (PICUs).

Purpose of the Study:

  • To evaluate the clinical outcomes of peptide-based formulas (PBF) compared to standard polymeric formulas (SPF) in critically ill pediatric patients.
  • To determine the impact of formula type on key clinical outcomes, including infection rates and nutritional intake.
  • To inform evidence-based decisions regarding enteral nutrition strategies in PICUs.

Main Methods:

  • A multicenter, prospective study involving pediatric patients receiving enteral nutrition in PICUs.
  • Comparison of patients receiving PBFs versus SPFs, utilizing propensity score matching and inverse probability of treatment weighting (IPTW) for adjustment.
  • Inclusion of 574 patients with analysis of baseline characteristics, caloric intake, and complication rates.

Main Results:

  • After IPTW adjustment, baseline characteristics were balanced. Early caloric intake by day 2 was higher with SPF (p < 0.001), but no difference was seen by day 7 (p = 0.853).
  • Nosocomial infections were significantly lower with PBF (17.6%) compared to SPF (23.5%) [OR = 0.7 (95% CI, 0.5-0.9); p = 0.015].
  • Constipation was more frequent with SPF (p = 0.010), and greater protein reduction was observed with SPF on day 2 (p < 0.001).

Conclusions:

  • While SPF facilitated earlier caloric and protein intake, overall outcomes were comparable by day 7.
  • PBF use was linked to reduced infection rates and less need for mechanical ventilation.
  • Individualized selection of enteral formulas is recommended, warranting further research to clarify optimal strategies.
Abstract

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...